ContextVision Presentation Q1 2022
ContextVision’s CEO Ola Lindblad will present the highlights for the first quarter 2022, followed by a Q&A session. Hosted by SpareBank 1 Markets Time: 22. April 2022 at 12.00 CET Register below:
Category ContextVision General
Exiting quarter and strong demand going forward
The quarter saw a very strong progress with a revenue of 27,2MSEK (20,3) and an EBITDA of 9,2MSEK (9,8). “It has been an exciting quarter where we have been able to establish the new organization and fully focus on Medical…
ContextVision – Invitation to Annual General Meeting 2022
STOCKHOLM – March 31, 2022 – ContextVision hereby invites shareholders to the Annual General Meeting on May 4, 2022. Please find attached the invitation including agenda and details on how to register and vote. Please contact: finance@contextvision.se for any questions regarding…
ContextVision presents Annual Report 2021
STOCKHOLM – March 31, 2022 – Please find ContextVision’s Annual Report 2021 attached. The report can also be found on the company’s website: www.contextvision.se Printed copies of the report will be distributed upon request by e-mail: finance@contextvision.se For inquiries, please contact…
ContextVision shows strong momentum in Q4, leading to record sales for the year
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK…
ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business.…
ContextVision – Information regarding dividend and reverse share split in Inify Laboratories
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected…
ContextVision confirms the value of the upcoming dividend
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15,…
ContextVision confirms the value of the upcoming dividend
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15,…
ContextVision announces resolution regarding record date for dividend
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to…